Oligometastatic Non-small Cell Lung Cancer (NSCLC) Clinical Trials in Villejuif, Île-de-France Region

First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.